News: Research and development

View:
 

Found press releases

 

Year-end report  January - December 2011

2/9/2012 2:00 AM EST  -   Biotage
Fourth quarter 2011

· Net sales are unchanged and are reported at 116.0 MSEK (116.1). At comparable exchange rates sales increased by 3 percent
· The operating result amounted to 9.8 MSEK (-435.9)1)
· A 7.3 MSEK (15.0) additional purchase payment for the Biosystems business area divested in 2008 was received from Qiagen
· The result after tax amounted to 17.2 MSEK (-424.8)1)
· Earnings per share amounted to...

Tackling financial exploitation of elderly people

2/8/2012 7:01 PM EST  -   The Economic and Social Research Council
Professionals who are in close contact with elderly people could soon be in a better position to spot if they are being financially exploited, for example through a lottery scam or by a deceitful relative draining the bank account, thanks to a pioneering new study funded by the UK Research Councils’ New Dynamics of Ageing programme (NDA)

Researchers have started to untangle the complex decision-making process that...

Medivir’s partner GSK initiates OTC launch of Xerclear® in Europe under trade na...

2/8/2012 2:30 AM EST  -   Medivir
Huddinge - Medivir AB (OMX: MVIR), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear®, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe. Xerclear® will be marketed under the trade name Zoviduo and Zovirax Duo in Europe.

In June 2010, Medivir...

East views the world differently to West

2/6/2012 4:41 AM EST  -   The Economic and Social Research Council
Cultural differences between the West and East are well documented, but a study shows that concrete differences also exist in how British and Chinese people recognise people and the world around them.  Easterners really do look at the world differently to Westerners, according to new research funded by the Economic and Social Research Council (ESRC). 

"British and Chinese people process visual information in very...

Dignity counts when caring for older people

2/3/2012 9:22 AM EST  -   The Economic and Social Research Council
Older people feel that their health problems pose a challenge to their sense of independence, dignity and identity and sometimes the health care they are given makes things worse.

According to research funded by UK Research Councils’ New Dynamics of Ageing programme (NDA), healthcare providers must avoid taking a ‘blanket view’ of how to help older people cope with the ageing process.

The study carried out by Dr...

Research on Firms’ Ability to Innovate Awarded EUR 100,000

2/2/2012 7:00 AM EST  -   Global Award For Entrepreneurship Research
Professor Kathleen Eisenhardt is the recipient of the prestigious Global Award for Entrepreneurship Research in 2012. Kathleen Eisenhardt is Professor of Management Science in Engineering at Stanford University, Stanford, CA, USA. She is awarded the prize for her distinguished and outstanding contributions to research on entrepreneurship, with an emphasis on “corporate entrepreneurship”. The amount of the prize is...

Diamyd Medical's Phase III study published in the New England Journal of Medicin...

2/2/2012 2:30 AM EST  -   Diamyd Medical
An article with the results of Diamyd Medical's European Phase III study of the antigen-based diabetes therapy Diamyd® has been published in the scientific journal the New England Journal of Medicine. The now published results were previously presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego, California, USA, on June 28, 2011.
The title of the published article is “GAD65...

ESS reaches 100 employees in the new Headquarters

2/1/2012 4:47 AM EST  -   European Spallation Source AB
The European Spallation Source Programme is growing fast and today welcomes the 100th employee in the new Headquarter building.
ESS will be the world-leading science facility for materials and life science research with neutrons. The ESS Programme is now in a design and build-up phase, with a fast growing and expanding organisation. This Monday, the ESS staff has moved into the new Headquarters in Medicon...

Are robots a threat or an asset? It’s up to you! - Press invitation for Robotics...

1/31/2012 7:48 AM EST  -   Robotdalen
February 9 the Swedish robotics cluster Robotdalen arranges the event Robotics Innovation Challenge in the city of Eskilstuna, Sweden. The day focuses on challenges, opportunities and solutions when developing new robots. What are the needs and can robots fulfil them? International experts share their point of view, new robots are presented on an innovation catwalk and the winner of the international prize...

YEAR-END REPORT 2011 CHRONTECH PHARMA AB (PUBL)

1/27/2012 1:10 AM EST  -   ChronTech Pharma AB

· Research and development costs amounted to SEK 15.2 (9.6) m
· The loss after tax was SEK -20.2 (-14.6) m
· Earnings per share were SEK -0.17 (-0.20)
· The company had no net sales for the period
· The controlled phase II clinical study of ChronVac-C® in combination with standard-of-care has started.
· ChronTech has entered as a partner in a collaborative project to improve on HCV vaccines with Karolinska...